Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on anti-dsDNA antibodies, the criteria stated a specification of ‘an abnormal anti-native DNA titer’ but they did not recommend any assay stringency or quality.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“The first classification criteria for SLE were formulated in 1971 by the American College of Rheumatology (ACR), followed by two revisions in 1982 and 1997.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“Both the 1971 and the revised 1982 criteria, further updated in 1997 by the ACR (formerly ARA) [17], required at least 4 of the 11 criteria for SLE classification to be present serially or simultaneously.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [10]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
ASHERSON, R. A., KHAMASHTA, M. A., ORDI-ROS, J., DERKSEN, R. H. W. M., MACHIN, S. J., BARQUINERO, J., OUTT, H. H., HARRIS, E. N., VILARDELL-TORRES, M., & HUGHES, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 959
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed · Cited by 723
ALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Exner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Cited by
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-162503 · Cited by 2,690
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40930 · Cited by 2,677
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
ACR AD HOC COMMITTEE ON NEUROPSYCHIATRIC LUPUS NOMENCLATURE (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<599::aid-anr2>3.0.co;2-f · Cited by 2,202
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Witness the efforts to define fibromyalgia (18, 19), chronic fatigue syndrome (19, 20), irritable bowel syndrome (21), systemic lupus erythematosus (22, 23), antiphospholipid syndrome (24), and metabolic syndrome (25– 27).”
BackgroundNavarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214819 · Cited by 1,612
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Hakkim, A., Fürnrohr, B. G., Amann, K., Laube, B., Abed, U. A., Brinkmann, V., Herrmann, M., Voll, R. E., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909927107 · Cited by 1,469
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Morand, E. F., Furie, R., Tanaka, Y., Bruce, I. N., Askanase, A. D., Richez, C., Bae, S.-C., Brohawn, P. Z., Pineda, L., Berglind, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912196 · Cited by 1,379
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
“All women with SLE satisfied the revised criteria for classification of SLE from the American College of Rheumatolog”
BackgroundVillanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., Rubin, C. J., Zhao, W., Olsen, S. H., Klinker, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100450 · Cited by 1,241
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1634 · Cited by 1,119
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z., Xu, J.-H., Cai, Z.-M., Huang, W., Zhao, G.-P., et al. (2009) · Nature Genetics · doi:10.1038/ng.472 · Cited by 936
Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
Hom, G., Graham, R. R., Modrek, B., Taylor, K. E., Ortmann, W., Garnier, S., Lee, A. T., Chung, S. A., Ferreira, R. C., Pant, P. V. K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707865 · Cited by 914
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Furie, R., Khamashta, M., Merrill, J. T., Werth, V. P., Kalunian, K., Brohawn, P., Illei, G. G., Drappa, J., Wang, L., Yoo, S., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39962 · Cited by 882
Sequential Therapies for Proliferative Lupus Nephritis
Contreras, G., Pardo, V., Leclercq, B., Lenz, O., Tozman, E., O'Nan, P., & Roth, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031855 · Cited by 818
Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R. C., Nordmark, G., et al. (2009) · Nature Genetics · doi:10.1038/ng.468 · Cited by 810
Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity
Liu, C.-X., Li, X., Nan, F., Jiang, S., Gao, X., Guo, S.-K., Xue, W., Cui, Y., Dong, K., Ding, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.046 · Cited by 807
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
Kim, J., Gupta, R., Blanco, L. P., Yang, S., Shteinfer-Kuzmine, A., Wang, K., Zhu, J., Yoon, H. E., Wang, X., Kerkhofs, M., et al. (2019) · Science · doi:10.1126/science.aav4011 · Cited by 793
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Franklyn, K., Lau, C. S., Navarra, S. V., Louthrenoo, W., Lateef, A., Hamijoyo, L., Wahono, C. S., Chen, S. L., Jin, O., Morton, S., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207726 · Cited by 764
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Update οn the diagnosis and management of systemic lupus erythematosus
Fanouriakis, A., Tziolos, N., Bertsias, G., & Boumpas, D. T. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218272 · Cited by 753
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases
Ramos-Casals, M., Brito-Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, L., Cuadrado, M.-J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 733
Defective B cell tolerance checkpoints in systemic lupus erythematosus
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., & Nussenzweig, M. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042251 · Cited by 717
Global epidemiology of systemic lupus erythematosus
Barber, M. R. W., Drenkard, C., Falasinnu, T., Hoi, A., Mak, A., Kow, N. Y., Svenungsson, E., Peterson, J., Clarke, A. E., & Ramsey-Goldman, R. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00668-1 · Cited by 709
Simpson, N., Gatenby, P. A., Wilson, A., Malik, S., Fulcher, D. A., Tangye, S. G., Manku, H., Vyse, T. J., Roncador, G., Huttley, G. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25032 · Cited by 684
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Graham, R. R., Kozyrev, S. V., Baechler, E. C., Reddy, M. V. P. L., Plenge, R. M., Bauer, J. W., Ortmann, W. A., Koeuth, T., Escribano, M. F. G., Collaborative Groups, T. A. A. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1782 · Cited by 671
Smyth, A., Oliveira, G. H. M., Lahr, B. D., Bailey, K. R., Norby, S. M., & Garovic, V. D. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240110 · Cited by 660
Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220647 · Cited by 654
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
The frequency and outcome of lupus nephritis: results from an international inception cohort study
Hanly, J. G., O’Keeffe, A. G., Su, L., Urowitz, M. B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Clarke, A. E., Wallace, D. J., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev311 · Cited by 647
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627
Tian, J., Zhang, D., Yao, X., Huang, Y., & Lu, Q. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223035 · Cited by 620
Manson, J. J., & Rahman, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-6 · Cited by 605
Valencia, X., Yarboro, C., Illei, G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 594
Follicular helper T cells are required for systemic autoimmunity
Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L., Cook, M. C., Walters, G. D., & Vinuesa, C. G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081886 · Cited by 587
Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis
Svegliati Baroni, S., Santillo, M., Bevilacqua, F., Luchetti, M., Spadoni, T., Mancini, M., Fraticelli, P., Sambo, P., Funaro, A., Kazlauskas, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052955 · Cited by 585
Wallace, D. J., Stohl, W., Furie, R. A., Lisse, J. R., McKay, J. D., Merrill, J. T., Petri, M. A., Ginzler, E. M., Chatham, W. W., McCune, W. J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24699 · Cited by 585
Sun, L., Akiyama, K., Zhang, H., Yamaza, T., Hou, Y., Zhao, S., Xu, T., Le, A., & Shi, S. (2009) · Stem Cells · doi:10.1002/stem.68 · Cited by 580
He, J., Zhang, X., Wei, Y., Sun, X., Chen, Y., Deng, J., Jin, Y., Gan, Y., Hu, X., Jia, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4148 · Cited by 572
Bruce, I. N., O'Keeffe, A. G., Farewell, V., Hanly, J. G., Manzi, S., Su, L., Gladman, D. D., Bae, S.-C., Sanchez-Guerrero, J., Romero-Diaz, J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205171 · Cited by 567
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study
Buyon, J. P., Kim, M. Y., Guerra, M. M., Laskin, C. A., Petri, M., Lockshin, M. D., Sammaritano, L., Branch, D. W., Porter, T. F., Sawitzke, A., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2235 · Cited by 567
Novel paradigms in systemic lupus erythematosus
Dörner, T., & Furie, R. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30546-x · Cited by 565
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. G., Rairie, J. E., Tracy, R. P., & Kuller, L. H. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<51::aid-anr7>3.0.co;2-d · Cited by 559
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R. R., & Behrens, T. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 556
Alarcón, G. S., McGwin, G., Bertoli, A. M., Fessler, B. J., Calvo-Alén, J., Bastian, H. M., Vilá, L. M., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068676 · Cited by 528
Fournier, P., Thuny, F., Richet, H., Lepidi, H., Casalta, J., Arzouni, J., Maurin, M., Célard, M., Mainardi, J., Caus, T., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/653675 · Cited by 506
Wallace, D. J., Furie, R. A., Tanaka, Y., Kalunian, K. C., Mosca, M., Petri, M. A., Dörner, T., Cardiel, M. H., Bruce, I. N., Gomez, E., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31363-1 · Cited by 513
Furie, R. A., Morand, E. F., Bruce, I. N., Manzi, S., Kalunian, K. C., Vital, E. M., Lawrence Ford, T., Gupta, R., Hiepe, F., Santiago, M., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30076-1 · Cited by 512
MicroRNA in autoimmunity and autoimmune diseases
Pauley, K. M., Cha, S., & Chan, E. K. L. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.012 · Cited by 508
Illei, G. G., Shirota, Y., Yarboro, C. H., Daruwalla, J., Tackey, E., Takada, K., Fleisher, T., Balow, J. E., & Lipsky, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27221 · Cited by 507
Troyanov, Y., Targoff, I. N., Tremblay, J.-L., Goulet, J.-R., Raymond, Y., & Senécal, J.-L. (2005) · Medicine · doi:10.1097/01.md.0000173991.74008.b0 · Cited by 506
Khamashta, M., Merrill, J. T., Werth, V. P., Furie, R., Kalunian, K., Illei, G. G., Drappa, J., Wang, L., & Greth, W. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208562 · Cited by 503
Houssiau, F. A., D'Cruz, D., Sangle, S., Remy, P., Vasconcelos, C., Petrovic, R., Fiehn, C., de Ramon Garrido, E., Gilboe, I.-M., Tektonidou, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131995 · Cited by 499
Novel evidence‐based systemic lupus erythematosus responder index
Furie, R. A., Petri, M. A., Wallace, D. J., Ginzler, E. M., Merrill, J. T., Stohl, W., Chatham, W. W., Strand, V., Weinstein, A., Chevrier, M. R., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24698 · Cited by 490
Oxidative stress and human health
Rahman, T., Hosen, I., Islam, M. M. T., & Shekhar, H. U. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.327123 · Cited by 489
Feldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., Winkelmayer, W. C., & Costenbader, K. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37795 · Cited by 487
Feng, X., Wu, H., Grossman, J. M., Hanvivadhanakul, P., FitzGerald, J. D., Park, G. S., Dong, X., Chen, W., Kim, M. H., Weng, H. H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22044 · Cited by 487
Furie, R. A., Aroca, G., Cascino, M. D., Garg, J. P., Rovin, B. H., Alvarez, A., Fragoso-Loyo, H., Zuta-Santillan, E., Schindler, T., Brunetta, P., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220920 · Cited by 459
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debré, P., Piette, J.-C., & Gorochov, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8392 · Cited by 456
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1114576 · Cited by 453
Somers, E. C., Marder, W., Cagnoli, P., Lewis, E. E., DeGuire, P., Gordon, C., Helmick, C. G., Wang, L., Wing, J. J., Dhar, J. P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38238 · Cited by 449
Glutathione peroxidase 4–regulated neutrophil ferroptosis induces systemic autoimmunity
Li, P., Jiang, M., Li, K., Li, H., Zhou, Y., Xiao, X., Xu, Y., Krishfield, S., Lipsky, P. E., Tsokos, G. C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00993-3 · Cited by 446
Vitamin D deficiency in systemic lupus erythematosus
Kamen, D. L., Cooper, G. S., Bouali, H., Shaftman, S. R., Hollis, B. W., & Gilkeson, G. S. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.05.009 · Cited by 445
Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L., & Li, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24499 · Cited by 444
Kavanaugh, A., Tomar, R., Reveille, J., Solomon, D. H., & Homburger, H. A. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0071-gfcuot · Cited by 443
Krishnan, Y., & Grodzinsky, A. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.005 · Cited by 443
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry
McClain, M. T., Heinlen, L. D., Dennis, G. J., Roebuck, J., Harley, J. B., & James, J. A. (2005) · Nature Medicine · doi:10.1038/nm1167 · Cited by 441
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
Azzouz, D., Omarbekova, A., Heguy, A., Schwudke, D., Gisch, N., Rovin, B. H., Caricchio, R., Buyon, J. P., Alekseyenko, A. V., & Silverman, G. J. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214856 · Cited by 436
McMahon, M., Grossman, J., FitzGerald, J., Dahlin‐Lee, E., Wallace, D. J., Thong, B. Y., Badsha, H., Kalunian, K., Charles, C., Navab, M., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21976 · Cited by 431
Lai, Z., Hanczko, R., Bonilla, E., Caza, T. N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34502 · Cited by 428
Petri, M., Stohl, W., Chatham, W., McCune, W. J., Chevrier, M., Ryel, J., Recta, V., Zhong, J., & Freimuth, W. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23678 · Cited by 428
Transancestral mapping and genetic load in systemic lupus erythematosus
Langefeld, C. D., Ainsworth, H. C., Graham, D. S. C., Kelly, J. A., Comeau, M. E., Marion, M. C., Howard, T. D., Ramos, P. S., Croker, J. A., Morris, D. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms16021 · Cited by 420
Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., Doria, A., Hammer, A. E., Kleoudis, C., Groark, J., Bass, D., Fox, N. L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40049 · Cited by 420
Chiche, L., Jourde‐Chiche, N., Whalen, E., Presnell, S., Gersuk, V., Dang, K., Anguiano, E., Quinn, C., Burtey, S., Berland, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38628 · Cited by 420
Scofield, R. H., Bruner, G. R., Namjou, B., Kimberly, R. P., Ramsey‐Goldman, R., Petri, M., Reveille, J. D., Alarcón, G. S., Vilá, L. M., Reid, J., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23701 · Cited by 417
Lai, Z.-W., Kelly, R., Winans, T., Marchena, I., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Tily, H., Francis, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30485-9 · Cited by 412
Higgs, B. W., Liu, Z., White, B., Zhu, W., White, W. I., Morehouse, C., Brohawn, P., Kiener, P. A., Richman, L., Fiorentino, D., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.150326 · Cited by 412
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Cohen, H., Hunt, B. J., Efthymiou, M., Arachchillage, D. R. J., Mackie, I. J., Clawson, S., Sylvestre, Y., Machin, S. J., Bertolaccini, M. L., Ruiz-Castellano, M., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30079-5 · Cited by 410
Yang, W., Shen, N., Ye, D.-Q., Liu, Q., Zhang, Y., Qian, X.-X., Hirankarn, N., Ying, D., Pan, H.-F., Mok, C. C., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000841 · Cited by 404
Epidemiology of systemic lupus erythematosus
Petri, M. (2002) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2002.0259 · Cited by 401
De Bandt, M., Sibilia, J., Le Loët, X., Prouzeau, S., Fautrel, B., Marcelli, C., Boucquillard, E., Siame, J. L., Mariette, X., & Inflammation, T. C. R. E. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1715 · Cited by 401
Smith, K. G. C., Jones, R. B., Burns, S. M., & Jayne, D. R. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22046 · Cited by 400
Bleeker-Rovers, C. P., Vos, F. J., de Kleijn, E. M. H. A., Mudde, A. H., Dofferhoff, T. S. M., Richter, C., Smilde, T. J., Krabbe, P. F. M., Oyen, W. J. G., & van der Meer, J. W. M. (2007) · Medicine · doi:10.1097/md.0b013e31802fe858 · Cited by 399
Jais, X., Launay, D., Yaici, A., Le Pavec, J., Tchérakian, C., Sitbon, O., Simonneau, G., & Humbert, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 398
Metadata
- Authors
- Hochberg, M. C.
- Affiliations
- American College of Rheumatology (US)
- Corresponding author
- Hochberg, Marc C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 40
- Issue
- 9
- Pages
- 1725-1725
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2070527591
- Cited by
- 11,409
- References
- 13
- Citations by year
- 2026: 283 · 2025: 422 · 2024: 515 · 2023: 530 · 2022: 652 · 2021: 701 · 2020: 616 · 2019: 631 · 2018: 634 · 2017: 675 · 2016: 621 · 2015: 633 · 2014: 625 · 2013: 563 · 2012: 490
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, American College of Rheumatology, disease classification, lupus diagnosis
- MeSH terms
- Diagnosis, Differential, Humans, Lupus Erythematosus, Systemic, Rheumatology, Societies, Medical, United States, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.